Skip to main content
Loading

Progressing biologics from early discovery to preclinical validation

04 May 2026
Cell Therapy Development
  • Overview of biologics discovery
  • Identifying and mitigating bottlenecks in selecting appropriate preclinical models
  • Strategies for evaluating efficacy and safety during early development
Industry Expert
Sanjivan Gautam, Director Oncology - AstraZeneca